Thursday - April 17, 2025

Regeneron Pharmaceuticals Assigned Patent

2016-10-06

ALEXANDRIA, Va., Oct. 6 -- Regeneron Pharmaceuticals, Tarrytown, New York, has been assigned a patent (9,459,263) developed by three co-inventors for VEGF-A.sub.121 assay. The co-inventors are Nicholas Papadopoulos, Lagrangeville, New York, Anthony Dore, Tarrytown, New York, and Douglas MacDonald, New York.

The patent application was filed on July 28, 2015 (14/811,056). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d= . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Regeneron Pharmaceuticals Assigned Patent

Information Request Form

Copyright Targeted News Service 2016